Jl Mag Rare-Earth (300748.SZ) has obtained the laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment (CNAS).
Jinli Permanent Magnet (300748.SZ) announced that the company has recently received the laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment (referred to as CNAS). The scope of recognized capabilities includes rare earth permanent magnetic materials and their products, as well as neodymium iron boron alloys and their products.
Jl Mag Rare-Earth (300748.SZ) announced that the company has recently received a laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment (referred to as "CNAS"). The scope of recognized capability includes rare earth permanent magnet materials and products, as well as neodymium iron boron alloys and products.
Relying on CNAS accreditation, the testing reports issued by the company within the recognized capability scope can carry the CNAS and ILAC-MRA mutual recognition symbols, which are recognized in many global economies. This helps eliminate international technical trade barriers, reduce duplicate testing costs, and further enhance the market acceptance of products.
Related Articles

ZYLOXTB (02190) spent HKD 1.1601 million to repurchase 53,000 shares on September 4.

YUEXIU PROPERTY (00123) has acquired a parcel of land in Tianhe District, Guangzhou, through its subsidiary for approximately 2.481 billion yuan.

InPha Pharmaceuticals (07630) has officially been included in the Hong Kong Stock Connect, opening up a channel for mainland investors to participate.
ZYLOXTB (02190) spent HKD 1.1601 million to repurchase 53,000 shares on September 4.

YUEXIU PROPERTY (00123) has acquired a parcel of land in Tianhe District, Guangzhou, through its subsidiary for approximately 2.481 billion yuan.

InPha Pharmaceuticals (07630) has officially been included in the Hong Kong Stock Connect, opening up a channel for mainland investors to participate.

RECOMMEND





